Supplier News

The latest developments from suppliers of ingredients, development and manufacturing services, and related technologies for pharmaceutical and biopharmaceutical development and production.

Debiopharm Group,  a Swiss-based global biopharmaceutical group of companies active in drug development, GMP manufacturing of proprietary drugs, diagnostics, and investments, has announced its decision to expand and optimize activities at...

The biopharmaceutical company Biodel Inc. has signed a long-term manufacturing agreement with Emergent BioSolutions under which Emergent will fill-finish commercial quantities of Biodel's glucagon emergency management (GEM)...

Parchem- fine & specialty chemicals, a supplier of active pharmaceutical ingredients, specialty intermediates, and excipients, has launched a new pharmaceutical division in Puerto Rico. Parchem's new pharmaceutical division will...

The global healthcare company Fresenius Kabi is establishing a $47-million pharmaceutical manufacturing facility and distribution center in Victoria, Australia, according to a press release by the Government of Victoria.  Fresenius Kabi...

Cobra Biologics and targeted cancer therapy company BioCancell have announced an agreement to manufacture BioCancell's BC-821 cancer drug for clinical trials. BioCancell's Phase I clinical trial for BC-821, scheduled to commence in 2015, is...

Dr. Hua Mu has been appointed senior vice-president of operations and global head of the product development service and partnership business unit at WuXi PharmaTech, reporting to Dr. Ge Li, chairman and chief executive officer. Dr. Mu has more...

Gallus BioPharmaceuticals (Gallus), a biologics contract manufacturing organization, has signed a manufacturing agreement with Symphogen, A/S (Symphogen), a private biopharmaceutical company developing recombinant monoclonal antibody (mAb) mixtures...

Connell Brothers (CBC), a division of Wilbur-Ellis Company and a marketer and distributor of specialty chemicals and ingredients in Asia-Pacific, has been appointed by FMC Corporation to distribute its pharmaceutical and pharmaceutical...

Metrics Inc. is opening a new $1.6-million, 4,524-square foot laboratory at its facility in Greenville, North Carolina, to better support fast-track development of pharmaceutical products. The new laboratory is designed for preclinical development...

Almac has added new blistering technology at its US commercial packaging facility in Audubon, Pennsylvania. The Klockner EAS blister line can produce a range of blister formats processing both thermoform and coldform material. The technology can be...

Cellceutix Corporation, a clinical-stage biopharmaceutical company developing innovative therapies in oncology, dermatology, and antibiotic applications, has selected Dr. Reddy's Custom Pharmaceutical Services (CPS), part of the Pharmaceutical...

Recipharm has contributed to setting up LSIS (Life Science Innovation Support), a network of privately-owned companies offering innovative services focused on contract-based research, development and manufacture within the life sciences. In...